Logo

Vol. 123, No. 5

May 28, 2013
On this page
β‑blockers in heart failure – are all created equal?
Romina Brignardello-Petersen, Gordon H. Guyatt
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 204–205; DOI: 10.20452/pamw.1720
Do primary care physicians follow the current recommendations for hypertensive pharmacotherapy?
Agnieszka Żak‑Gołąb, Michał Holecki, Mike Smertka, Jerzy Chudek
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 206–214; DOI: 10.20452/pamw.1722
Assessment of leptin and resistin levels in patients with chronic obstructive pulmonary disease
Anna Kumor‑Kisielewska, Dorota Kierszniewska‑Stępień, Tadeusz Pietras, Jadwiga Kroczyńska‑Bednarek, Zofia Kurmanowska, Adam Antczak, Paweł Górski
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 215–220; DOI: 10.20452/pamw.1724
Safety of enhanced renin–angiotensin–aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
Sławomir Lizakowski, Leszek Tylicki, Przemysław Rutkowski, Marcin Renke, Beata Sulikowska, Zbigniew Heleniak, Rafał Donderski, Rafał Bednarski, Milena Przybylska, Jacek Manitius, Bolesław Rutkowski
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 221–227; DOI: 10.20452/pamw.1726
Role of preprocedural glutathione concentrations in the prediction of major adverse cardiac events in patients with acute coronary syndrome treated with percutaneous coronary intervention
Robert Pietruszyński, Leszek Markuszewski, Konrad Masiarek, Marcin Makowski, Weronika Retelewska, Cezary Watala
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 228–237; DOI: 10.20452/pamw.1728
One‑year follow‑up of the Polish subset of the RecordAF registry of patients with newly diagnosed atrial fibrillation
Grzegorz Opolski, Dariusz A. Kosior, Michał Kurzelewski, Günter Breithardt; the Polish RecordAF Investigators
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 238–245; DOI: 10.20452/pamw.1730
New horizons in allergy diagnostics and treatment
Rafał Pawliczak
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 246–250; DOI: 10.20452/pamw.1732
Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia
Maciej Machaczka, Maria Gossart
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 251–252; DOI: 10.20452/pamw.1734
Cardiac involvement in hypereosinophilic syndrome
Tomasz Miszalski‑Jamka, Wojciech Szczeklik, Barbara Sokołowska, Krzysztof Karwat, Przemysław Jaźwiec, Jacek Musiał
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 253–254; DOI: 10.20452/pamw.1736
Unusual case of phosphaturic mesenchymal tumor
Lucyna Papierska, Jarosław B, Ćwikła, Waldemar Misiorowski, Michał Rabijewski, Krzysztof Sikora, Hubert Wanyura
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 255–256; DOI: 10.20452/pamw.1738
Bone marrow suppression with plasma cell leukemia‑like reaction complicated by macrophage activation syndrome after metamizole overuse
Artur Jurczyszyn, Anna Engel, Stanisława Bazan-Socha, Jacek Czepiel, Grażyna Biesiada, Aleksander B. Skotnicki
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 257–258; DOI: 10.20452/pamw.1740
Tamoxifen as the possible cause of severe thromboembolic complications in a patient with a history of renal transplantation and encapsulating peritoneal sclerosis
Anna Pawłowska, Bogna Kwella, Józef Kozak, Grzegorz Wasilewski, Tomasz Stompór
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 259–261; DOI: 10.20452/pamw.1742
Tamoxifen as the possible cause of severe thromboembolic complications in a patient with a history of renal transplantation and encapsulating peritoneal sclerosis: authors' reply
Tomasz Jakimowicz, Ewa Wojtaszek, Titus Augustine, Agnieszka Grzejszczak, Joanna Matuszkiewicz-Rowińska
Pol Arch Intern Med. 2013, Vol. 123, No. 5: 259–261; DOI: 10.20452/pamw.1744